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Abstract-We have examined 12 unlinked polymorphic genetic marker systems and found 6 
which each identified small but statistically significant differences in normal serum cholesterol 
levels which did not change significantly with age. The effects associated with 4 of the 6-ABO. 
haptoglobin, Gm and secretor-were consistent in males and females and combined additively to 
define effects which were also homogeneous over age. There was a marker phenotype by age 
interaction effect on cholesterol variance in females but not in males. This study supports the 
hypothesis that a number of polymorphic genes, each with a small additive effect on cholesterol 
level. play an important role in determining cholesterol variability. 
INTRODUCTION 
THE LEVEL of serum cholesterol has been found to be one of the primary indicators of 
risk to coronary heart disease in Caucasian populations, along with blood pressure. 
blood glucose and smoking [l-4]. We have conducted a number of studies in the 
Tecumseh, Michigan, population to estimate the relative contributions of shared genes 
and shared environments to the observed aggregation of cholesterol levels in families. 
After adjustment for variability in age, replicate measurements and socioeconomic status. 
we have estimated that 58.5% (SE = 3.8%) of the variance of In cholesterol in the 
population is associated with unspecified genetic factors [5]. We found that 9.83, 
(SE = 3.1”;) of the variance of parental values and 7.716 (SE = 3.3”,,,) of the offspring 
variance were attributable to variability among household environments. The relative 
contribution of the shared genetic and shared household environmental factors to fam- 
ilial aggregation in Tecumseh is remarkably similar to that estimated by Rao and his 
colleagues [6] in a study of Japanese-Hawaiians. 
A question of major interest in genetic epidemiology is whether the genetic effects 
which contribute to phenotype variability combine additively with the effects of environ- 
ment. The implications of genotype by ‘environment (G x E) interaction in interpreting 
genetic and environmental determinants of quantitative variability are discussed by a 
number of investigators [7-l 11. To answer the question, one must have measures of both 
the relevant environments and the genetic effects involved in determining the phenotype. 
Neither is easy to obtain in a large epidemiological survey. In an effort to shed light on 
the contribution of G x E interaction to cholesterol variability in Tecumseh, we selected 
age as an index of a number of environments which might be expected to change over the 
lifetime of the individual; e.g. maturation, diet, physical activity, stress and socioecon- 
omic status may all influence the expression of genes which are involved in determining 
lipid levels. Specific gene effects could be measured by inherited variations in gene 
products directly involved in cholesterol metabolism or by polymorphic genetic blood 
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and serum markers which are closely linked to such loci. Unfortunately, the only loci 
which have been found to be directly involved have mutant alleles which are rare in 
frequency [12]. However, a number of studies have found associations between choles- 
terol levels and certain polymorphic genetic markers, most notably ABO and secretor 
[13, 143. The consistency of observed effects among studies and between sexes within 
studies suggests that the loci identified by these genetic markers may either themselves be 
involved in cholesterol metabolism or be very closely linked to the loci which are. 
A marker phenotype by age (MP x A) interaction could be expressed by different 
relationships among the means or among the variances estimated for the marker pheno- 
typic classes at different ages. Up to now, all studies examining the relationships between 
cholesterol and genetic markers have been conducted using individuals representing a 
limited range of ages, with the exception of our earlier study [14], which was based on 
age-adjusted data. To pursue the question of whether marker phenotype effects are 
consistent for all ages, we studied changes in both the mean and variance of In choles- 
terol over the age range 4-92. 
SAMPLE AND ANALYTICAL STRATEGY 
The data under study are from the Tecumseh, Michigan, Community Health Study, 
which has been described previously [15-173. A description of available serum choles- 
terol data and the method of laboratory analysis have appeared elsewhere [18]. A total 
of 3095 males and 3227 females had age and non-fasting serum cholesterol recorded 
between 1963 and 1966 and were typed for each of 12 unlinked polymorphic genetic 
blood and serum markers. The systems included Gm, Gc, haptoglobin, MNS, Rh, Duffy, 
P, ABH secretion, Lewis secretion, Kell, Kidd and ABO. The phenotypes considered and 
their relationships to single-locus genotypes are described in Table 1 of a previous study 
[14]. Individuals in this sample ranged in age from 4 to 92. Skewness in the frequency 
distribution of cholesterol [lS] made it appropriate to transform all values by the natural 
logarithm (In). 
Our previous studies [18] established that a third-order polynomial best described the 
relationship of In cholesterol and age. Figure 1 shows the best-fitting third-order regres- 
sions of In cholesterol on age for males and females. Because the regression relationship 
in rnales was significantly different from that in females, we considered the sexes separ- 
ately for the study of marker effects on cholesterol prediction at different ages. 
A study of cholesterol variability by Moll er al. [19] suggested that segregation at one 
or more loci with a major effect and extreme environmental effects associated with 
certain households are likely to be present in the Tecumseh population. Investigations of 
the families of hypo- and hypercholesterolemic individuals suggested that they represent 
heterogeneous contributions of genetic and environmental etiologies which present a 
different kind of research problem than arises with the normocholesterolemic population. 
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Fig. 1. Third-order regressions of In cholesterol on age for males and females in Tecumseh. 
Michigan. 
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1 2 1 2 3 
Percent of individuals 
included 
Ln cholesterol mean 
(antilog-mg%) 
Standard deviation* 
0.96 99.04 0.63 97.37 2.00 
4.822 5.302 4.849 5.303 5.655 
(124.2) (200.7) (127.6) (200.9) (285.7) 
0.1640 0.1586 
* The variances of the distinct distributions were not found to be different at the 
0.10 level of significance in either sex. 
Because our aim was to investigate the interaction of genetic and environmental effects 
on normu/ cholesterol variability, we chose to eliminate from our sample those individ- 
uals representing extreme effects. We began by examining the sample defined earlier [14], 
using the maximum likelihood method of Day [ZO] to determine if more than one 
frequency distribution was necessary to describe In cholesterol for males and/or females 
in the Tecumseh population. Table 1 gives the estimates of the parameters of the best-fit- 
ting distributions for each sex. About l”/:, of the sample of males belongs to a second 
distribution with a lower mean cholesterol. Three distinct distributions of females were 
detected. The distributions with the highest and lowest means included a total of 2.67; of 
the female sample. To assign an individual to a distribution, we divided the areas of 
distribution overlap into 6 equal segments. The estimates of the parameters of the distri- 
butions given in Table 1 were used to define each segment, assuming a mixture of normal 
probability functions. We randomly selected from each segment those individuals to be 
assigned to the distribution of extreme cholesterol values. Individuals identified as being 
in the distributions representing the extreme values were removed from further consider- 
ation, along with every member of their household. Although eliminating such house- 
holds may not totally remove the major gene and extreme environmental effects from our 
sample, in the households that remain such effects are not expressed, if they do exist. 
Approximately 5.47; of the males and 5.7g; of the females resided in the households 
identified as having extreme effects, leaving 2929 males and 3043 females to be analyzed 
for MP x A interaction. The third-order polynomials for all data, given in Fig. 1, were 
not significantly altered in this subset of data. 
To identify MP x A interaction effects on the level of cholesterol, we investigated the 
variability of the third-order regression of In cholesterol on age among marker pheno- 
types using the analysis of covariance. The traditional error mean squares used for 
testing the hypotheses of equal regression slopes and equal age-adjusted phenotype 
means would underestimate the expected error variances because members of the same 
household share genes and/or environmental effects. An appropriate error term was 
computed as a function of mean squares [21] obtained by carrying out the nested 
analysis of variance we described previously [14] on the In cholesterol values adjusted 
for a third-order age regression. In order to accommodate this nested design, when more 
than one phenotype for a given system was present in a household, only one was chosen 
(at random without regard to the number of individuals in the household with that 
phenotype) to represent the household in the analysis of marker effects. Each system was 
considered independently; as a result, the composition of the subsamples differed some- 
what among systems. The redefinition of the sample to obtain a valid error term reduced 
the amount of data available by between 8 and 11:; for dominant marker systems and 
between 14 and 19% for codominant systems. 
Before proceeding to an analysis of covariance to detect MP x A interaction and 
marker phenotype effects on lipid levels for each of the 12 systems in this study, we 
examined the distribution of the variance of In cholesterol among phenotype and age 
classes. The variance is of interest for two reasons. First, two assumptions of the analysis 
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of covariance are that the variance about the regression curve for each phenotype is 
constant over all ages and that the variances of In cholesterol within marker phenotype 
classes are equal. Failure for these assumptions to be true would invalidate the conclu- 
sions one might draw from an analysis of covariance. Second, heterogeneity of variance is 
another measure of the failure of all genotypes to respond similarly to a population of 
environments. If the variance is homogeneous over age for each marker phenotype, this 
type of genotype by age interaction would not be indicated. The same conclusion could 
be drawn even if the variances were heterogeneous over age, provided the pattern of 
change in variance was the same in each phenotype. However, if the pattern of change in 
variance differed significantly among marker phenotypes, we would have evidence for a 
genotype by age interaction effect on cholesterol variability. 
To examine the distribution of the variance among 5-yr age cohorts and marker 
phenotypes, we made use of a modification of the procedure of Bartlett [22] to carry out 
a two-way analysis of heterogeneity of variance. We calculated Bartlett’s chi-square 
statistic for heterogeneity of variance among R age classes, among C marker phenotypes, 
and among the R x C age-phenotype combinations. A chi-square for testing the 
MP x A interaction effect on variance was calculated by subtracting the age and marker 
phenotype chi-squares (with R - 1 and C - 1 degrees of freedom, respectively) from the 
chi-square computed on the age-phenotype cells (with N - 1 degrees of freedom, where 
N = R x C). The degrees of freedom for the test of interaction were taken to be 
N - R - C - 1. This procedure was followed for each marker system in each sex. 
In the absence of heterogeneity of variance, the investigation of marker effects on mean 
cholesterol levels over age began with a test of the hypothesis that the regression curves 
for each phenotype were parallel. If we failed to reject this hypothesis (meaning there was 
no indication of MP x A interaction), we proceeded to test the hypothesis that the 
age-adjusted phenotype means were equal. If we found that the age-adjusted means were 
significantly different from one another, we concluded that the marker system under 
study identified a genetic effect on cholesterol and that this effect was consistent over all 
ages. If we rejected the first hypothesis, that the regression relationships were the same, 
we concluded that the marker phenotypes predicted cholesterol differently at different 
ages, in which case there was evidence for a genotype by age (environment) interaction. A 
model appropriate for the interpretation of G x E interaction will be included with the 
discussion of the statistical analyses presented below. 
RESULTS 
Heterogeneity of variance 
For males, we found that the chi-square measure of the MP x A interaction effect on 
variance was significant at the 0.05 level of probability only for the MN system. Ignoring 
age, Kell was the only system for males which identified statistically significant differ- 
ences in variance among marker phenotypes. In view of the fact that we analyzed 12 
independent marker systems, it is reasonable to dismiss the single significant result for 
each type of test (of interaction and of marker effects) as a type I error. Neither MP x A 
interaction effects on variance nor heterogeneity of variance among marker phenotypes 
appears to be a major characteristic of the male data from Tecumseh. 
In contrast to the findings in males, MP x A interaction effects on variance were 
significant at the 0.05 level of probability for the ABO, haptoglobin, secretor, Kidd and P 
systems for females. In addition, the test for interaction was significant at the 0.08 level 
for the Gc, Duffy and Rh D systems, suggesting that in as many as 8 of the 12 marker 
systems we studied, the interaction of genotype with environmental factors indexed by 
age may play an important role in the determination of cholesterol variability for 
females. 
If there were no MP x A interaction effect on variance, we would expect variability 
within each marker phenotype to change approximately the same amount from one S-yr 
age cohort to the next. The detection of an interaction effect in females implies that the 
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Fig. 2. Variances of In cholesterol in phenotypes of 4 polymorphic marker systems in 5-yr age 
cohorts for females. 
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changes in the variance from one age cohort to the next differ among the phenotypes of a 
marker system. The plots of the variance against age class within each marker phenotype 
suggest that interaction effects are, for the most part, attributable to changes in rank of 
the marker phenotypes at 15,45 or 65 yr of age for all but the Kidd and Gc systems. To 
illustrate, the plots for P, ABO, and secretor are given in Figs 2a, 2b and 2c, respectively. 
The P2 phenotype predicts lower variance in the 2&44 and 65-92 age ranges, whereas 
the 0 and secretor phenotypes predict greater variance in the 45-69 and the 4&79 age 
ranges, respectively. For statistical comparisons, we pooled the 16 5-yr age cohorts into 
four: 4-14, 154, 45-64 and 65-92. We then re-examined the differences among vari- 
ances estimated for each of the marker phenotypes within the pooled cohorts for all 
systems. Statistically significant (at the 0.05 level of probability) differences in the vari- 
ance among individuals aged 154 having different marker phenotypes were detected for 
P, Duffy and S, while the secretor, haptoglobin, Rh D, P and S systems identified 
significant heterogeneity among phenotypic classes in the 65-92 age category. ABO is the 
only system where significant phenotypic differences in variance were detected in the 
45-64 age class. 
There were 4 independent marker systems where no significant interaction was indi- 
cated for females. Of these, only for the S system was there statistically significant 
heterogeneity of variance among phenotypes ignoring age. Figure 2d illustrates the lower 
variance among females aged 10-45 who are homozygous S. 
Since the marginal variances in the 16 age cohorts were based on nearly the same data 
for the analysis of each system, we investigated the variances of In cholesterol among age 
cohorts ignoring marker phenotype. The variance was significantly heterogeneous at the 
0.05 level of probability for both sexes. Greater variance was observed between ages 15 
and 30 and between 60 and 80. The biological ramifications of the observed hetero- 
geneity of variance will be discussed below. 
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TABLE 2. RESULTS OF TE.VS(~ = ~.O~)FOR MARKER PHENOTYPE BY AGE INTERACTION AND 
MARKER PHENOTYPE EFFECTS ON CHOLESTEROL 
Significant marker phenotype mean effects* 
Interaction 
with age? Consistent 























sese > Se- 
non-0 > 0 
E- > ee 
No test 
22z l- 
a- > bb 
sese > Se- 








* After correction of data for third-order relationship with age. 
Heterogeneity of regression on age among marker phenotypes 
Because heterogeneity of error variance violates an assumption of the analysis of 
covariance we have proposed, we proceeded with a weighted analysis which utilized the 
inverse of the subclass variances [23] to investigate MP x A interaction effects on mean 
cholesterol levels. Table 2 summarizes the results of our search for MP x A interaction 
and marker phenotype effects. Statistically significant interaction was not found for any 
of the 12 marker systems in males and only for the Gc system in females. Figure 3 shows 
that the predicted In cholesterol of the Gc heterozygote rises nearly uniformly, while the 
predictions for the two homozygotes change in the same third-order way that the overall 
population mean changes with age. Out of the 24 independent tests of interaction, it is 
expected that one would be significant by chance alone; therefore, we chose to interpret 
the Gc interaction to be a spurious result. Confirmation of this interaction in an indepen- 
dent study, however, would suggest that genetic effects marked by Gc may not be 
independent of the changes which are occurring with age. 
Differences among age-adjusted marker phenotype means significant at the 0.05 level 
of probability were found for the ABO and Rh E systems in males, for the haptoglobin, 
Gm and Duffy systems in females, and for the secretor system in both sexes (Table 2). 
Such differences could not be appropriately tested in females for the Gc system over all 
ages since MP x A interaction effects were found to be significant in that case. A signifi- 
cant difference was found among the Gc phenotype means only for those in the age range 
4-14. Table 3 gives the adjusted means and standard errors for each phenotype of each of 
the six marker systems in both sexes. In an effort to establish the nature of the effects 
which determined the significant heterogeneity of mean cholesterol among marker 
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Fig. 3. Third-order regression of In cholesterol on age for phenotypes of the Gc system for 
females. 
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TABLE 3. AGE-ADJUSTED LN CHOLESTEROL MEANS AND THEIR STANDARD ERRORS FOR EACH PHENOTYPE OF THE 6 
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5.3458 k 0.00604 
5.3482 + 0.01271 
5.3441 * 0.01119 
5.3396 + 0.02348 
5.2870 +- 0.03364 
5.3163 + 0.00542 
5.3444 & 0.00480 
5.3228 + 0.00931 
5.3284 f 0.00510 
5.3389 Ifr 0.00643 
5.3270 f 0.00451 
5.3383 + 0.01106 
5.3338 & 0.00534 
5.3239 If 0.00528 
5.3346 + 0.00485 
5.3177 * 0.00399 
5.3477 + 0.00702 
5.3621 + 0.02393 
5.3392 + 0.00660 
5.3204 f 0.00413 
5.3412 T 0.00645 
5.3319 + 0.00419 








































5.3298 + 0.00564 
5.3259 + 0.01161 
5.3520 + 0.01232 
5.3060 f 0.02011 
5.2863 + 0.03134 
5.3263 ? 0.00510 
5.3306 + 0.00457 
5.3220 f 0.00849 
5.3246 + 0.00483 
5.3447 + 0.00597 
5.3240 f 0.00422 
5.3339 + 0.01075 
5.3385 + 0.00524 
5.3200 f 0.00487 
5.3376 + 0.00474 
5.3216 _+ 0.00385 
5.3422 + 0.00647 
5.3103 f 0.01791 
5.3181 + 0.00689 
5.3269 + 0.00382 
5.3174 * o.c@655 
5.3221 + 0.00408 
























phenotypes, we used Scheffe’s simultaneous contrasts. This analysis identified two classes 
of phenotypes for each marker system. ABO was divided into 0 and non-0 phenotypes, 
while in the haptoglobin, Gm and Rh E systems the heterozygote was combined with one 
of the homozygotes. The means and their standard errors for the combined phenotypes 
also appear in Table 3. When the six marker systems were each represented by two 
phenotypic classes, the significant age-adjusted mean differences ranged from 2.9 mg% for 
Duffy in females to 6.2 mg% for secretor in males. 
The estimated changes in mean cholesterol over age for each of the marker phenotypes 
of the six systems identified are given in Fig. 4. As expected from the covariance analysis, 
the regressions estimated for the phenotypic classes of a marker. system are parallel for 
every one of the six marker systems for both males and females. That these regressions 
are parallel illustrates that the gene loci marked by these systems contribute independent 
of age to the prediction of differences in cholesterol level. In both sexes, the mean 
age-adjusted In cholesterol of the nonsecretors was significantly higher than that of the 
secretors. While the haptoglobin, Gm and ABO age-adjusted contrasts were significant in 
only one sex, the rank order of the means of the phenotypic classes for those systems was 
the same in the sex where the differences were not significant. Consistent ranking of the 
marker effects in both sexes, even if the effects were statistically significant in only one 
sex, is viewed as evidence that a marked gene effect is being expressed in the Tecumseh 
population. In the case of Rh E and Duffy, the observed effects were inconsistent between 
males and females; hence, they could reflect either sex-specific effects or a spurious 
marker effect in one sex. 
Multilocus heterogeneit) 
Having considered each marker system apart from the others, we proceeded to exam- 
ine cholesterol levels when the marker systems were considered simultaneously. To do 
this, we chose the four systems where the age-adjusted means were significantly different 
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Fig. 4. Third-order regressions of In cholesterol on age for the phenotypes of 6 systems where a 
statistically significant marker phenotype effect was observed in one or both sexes. 
among phenotypes in at least one sex and ordered the same in both sexes, i.e. ABO, 
haptoglobin, Gm and secretor. We identified for each system a ‘positive marker effect’, 
that is, the phenotypic classes that we associated with higher cholesterol values. Table 3 
shows that the positive effects were associated with the non-9 Hp 22, Gm a- and 
nonsecretor phenotypic classes. An individual’s multilocus marker phenotype was 
defined as the number of positive marker effects that individual had. Figure 5 shows the 
regressions of In cholesterol on age for each of these multilocus phenotypes, separately 
for males and females. 
Before considering the statistical properties of the relationship of age with multilocus 
phenotype means, we examined the distribution of variance among multilocus pheno- 
types and age classes. Using the two-way analysis of heterogeneity of variance described 
above, we found a multilocus phenotype by age interaction effect on variance which was 
significant at the 0.05 level of probability for females. No multilocus marker phenotype 
had significantly greater or smaller variance than the others over any large age range. 
For males there was no significant heterogeneity of variance with respect to the number 
of positive marker effects. Because of the observed heterogeneity of variance, a weighted 
analysis of covariance (like that used in the analysis of single-locus effects) was used to 
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Fig. 5. Third-order regressions of In cholesterol on age for the multilocus marker phenotypes. 
test for multilocus phenotype by age interaction Gfects on cholesterol levels. This analy- 
sis indicated that the regression relationships were not significantly different among 
multilocus phenotypes at the 0.10 level of probability for either sex; hence, we conclude 
that there is no evidence for a multilocus phenotype by age interaction effect on means. 
The age-adjusted means, which appear in Table 4 along with their standard errors, 
increased with the number of positive effects in both sexes. A difference of approximately 
18 mg% was predicted by these four marker systems in both sexes. The regressions in 
Fig. 5 show that the rank order of the means of the multilocus phenotypes prevailed from 
age 15 to 65, with the exceptions that males with 2 positive effects had slightly greater 
mean cholesterol after age 35 than those with 3 positive effects and females with 1 
positive effect had slightly greater mean cholesterol between ages 30 and 55 than those 
with 2 positive effects. The age-adjusted means of the involved phenotypes were so close 
together that it is not surprising that their order be reversed at some ages; and, the 
reversal of order was not great enough in these data to cause a statistically significant 
multilocus phenotype by age interaction. The increase in mean cholesterol, which was 
consistent over age, with the number of positive marker effects indicates that these 
polymorphic genetic markers, or genetic loci which are closely linked to them, are each 
responsible for a small, additive effect on cholesterol level which is statistically indepen- 
dent of the age of an individual. 
DISCUSSION 
Our statistical analyses of the distribution of serum cholesterol across age cohorts 
suggest two conclusions. First, the statistically significant genetic effects on the level of 
TABLET. AGE-ADIUSTEDLNCH~LESTEROLMEANSANDTHEIR STANDARD 
ERRORSFOR MULTILOCUS PHENOTYPES BASED ON THE NUMBER OF POSI- 
TIVE MARKER EFFECTS 
No. positive Sample Adjusted mean 
effects size Ln Chol + SE Antilog 
Males 0 167 5.3140 f 0.01482 
1 595 5.3339 + 0.00711 
2 120 5.3654 $- 0.00686 
3 274 5.3672 f 0.01008 
4 37 5.4015 f 0.03038 
Females 0 193 5.3241 + 0.01276 
I 645 5.3509 + 0.00676 
2 747 5.3554 k 0.00669 
3 315 5.3717 + 0.00934 
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age-adjusted cholesterol identified by four polymorphic blood and serum marker systems 
that we reported earlier [14] are consistent in their size and direction over all age classes 
for both sexes. Second, 8 of the 12 marker systems studied identified significant genetic 
effects on phenotypic variability at specific periods of life in females but not in males. A 
meaningful discussion of the biological interpretations of these results cannot be under- 
taken without establishing a concise definition of the population of genetic and environ- 
mental effects that are represented in the sample which was subjected to the statistical 
analysis. Because we do not have direct measures of the genes and the environments 
which contribute to each individual’s cholesterol phenotype, we must construct a math- 
ematical definition of these factors that is based on an appropriate stratification of the 
sample of phenotypes. Such a definition involves the assignment of a phenotypic value to 
each genotypic and environmental stratification considered by our study and knowledge 
about the joint frequency distribution of those values. 
We will follow the arguments developed by Comstock and Moll [24] to model the 
observed effects of age and marker phenotype on the level and variability of serum 
cholesterol in terms of the contribution of genetic and environmental sources of pheno- 
typic variability. A convenient linear model which describes the contribution of genetic 
and environmental effects which are identified by the analytical design of this study may 
be written 
Pijk = ~1 + Gi + Ej + GE,, + eijk. 
Here G, E, GE and e are unmeasured random variables that define, respectively, the 
separate contributions of genotype, the macroenvironment defined by age class, an inter- 
action between the genotype and the age-specific environmental effects, and a random 
environmental effect within the age-genotype class. The value of each of these variables 
is taken to be the deviation of the mean of an appropriate subset of individuals from the 
mean of all individuals of the population under consideration. For example, the expected 
genetic contribution to the phenotype of the individual with the ith genotype is taken to 
be the deviation from the overall mean (cl) of the average phenotype of all individuals 
with the ith genotype weighted by the relative frequency of the ith genotype class. In our 
study, classes of genotypes are identified by the marker phenotypes. Defined in this way, 
the value of each genotype depends on the phenotypes it produces and these, of course, 
depend on the environments experienced. Consequently, the interpretation of the ith 
genotype value as Pi., = p + Gi depends on the distribution of the population of geno- 
typic effects with respect to the factors defined by the variables E and e. Before consider- 
ing the consequences of this definition, we similarly define Ej as the deviation of the jth 
age class mean from p and t?ijk as the deviation of the value of the kth individual from the 
mean of the ith genotype in the jth age class studied. Age indexes a class of environmen- 
tal factors whose effects are distributed among age cohorts. In this study the jth environ- 
mental value, P,j, = p + Ej, is taken to be the average of those individuals who experience 
the jth combination of macroenvironmental outcomes that vary among the 5-yr age 
classes. Diet, exposure to pollutants, stress, physical activity and any other factors which 
vary as a function of age may be candidates. 
The Gi and Ej effects are independent measures of genotype and environment, respect- 
ively, only if their frequency distributions are uncorrelated; that is, 
f(GEij) =f(GJ x f(Ej). If certain genotypes are found in certain age groups more (or 
less) often than expected, it is not possible to contrast genotype values in different age 
classes in a meaningful way. Simply, genotype values may compare differently in different 
age strata, not because the effects of the genotypes are different, but because they are 
differentially represented in the strata being compared. The assumption of independence 
of the frequencies of the Gi and Ej effects in this study is supported by an earlier analysis 
[25] which found that estimates of both the phenotype and the allele frequencies for each 
of the 12 markers considered here were not significantly heterogeneous among age 
classes in these data. With this assurance it is reasonable, then, to proceed to define an 
interaction effect GE,, as the failure of the genetic effect estimated by the ith genotype 
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value and the environmental effect estimated by the average of all individuals in the jth 
age class to explain the average phenotype of those individuals with the ith genotype who 
fall in the jth age class. The distribution of G x E interaction effects explains the varia- 
bility among the means of subclasses defined by the ith genotype and the jth macro- 
environment (Pij,) not accounted for by the distribution of the genotypic and environmen- 
tal values about the overall mean. An exact definition of the variabile eijk remains. For 
the analysis presented above, eijk represents the deviation of the kth individual from 
Pij, = p + Gi + Ej + GE,,. With this model the total phenotypic variance of In choles- 
terol can be partitioned thusly: 
2 
UP 
= 0; +  a; +  CT& + CJ’, 
where the subscripts define the associated variances. The phenotypic variance for the ith 
genotype and the ,jth environment is defined 
and is attributable to those genetic and microenvironmental differences not accounted 
for by the definition of Gi and Ej used here. 
Environments can interact with genotypes to cause several different types of effects on 
the resultant phenotype. One type of G x E interaction effect, and that which is most 
often examined, is that on location, or the average value of the phenotype. In terms of the 
model, when interaction is present, the interaction effect GE{, is not identically zero for 
all combinations of genotypes and all environments; equivalently, a& is not equal to 
zero. Heterogeneity of a:,, among subclasses defined by the ith genotype and the jth 
environment is a second type of interaction between genotype and environment. Murphy 
[26] points out the importance of utilizing the second and higher moments of data and 
laments that such analyses are too infrequently called upon to understand more fully the 
biological basis of a trait. 
Variability among individuals within each marker phenotype-age subclass, a$_, may be 
attributable to the expression of unmeasured genetic and microenvironmental factors 
which are randomly distributed within each marker-age subclass. The heterogeneity of 
this variance among subclasses may be due to the involvement of genetic and/or environ- 
mental factors that are randomly distributed in all subclasses but expressed only in those 
individuals with specific marker phenotypes and belonging to specific age classes. The 
differential response of marked genotypes to the microenvironments in different age 
classes is manifested by statistically significant heterogeneity of variance among marker 
phenotype-age classes. This type of effect of genotype on phenotypic variability has been 
defined by Lerner [27] as differential homeostasis (where the stability of phenotype 
variability in different macroenvironments depends on the genotype) and by Bradshaw 
[28] as differential phenotypic plasticity. Heterogeneity of variance among subclasses 
might also be attributable in part to a correlation between unmeasured genetic and 
random microenvironmental effects and the marker phenotype-age strata. Such a corre- 
lation is impossible to separate from G x E interaction in a cross-sectional survey of this 
type. That there is heterogeneity of variance among age strata suggests that unmeasured 
genetic and microenvironmental factors may not be randomly distributed in these data. 
The formal definitions of the effects specified in the model above should leave no 
doubt that when one speaks of the effect of a particular genotype or of a particular 
environment, it is in the context of a particular population of environments and a 
particular population of genotypes, respectively. Furthermore, the genetic interpretation 
of the difference between two genotype values has little meaning when there is G x E 
interaction unless one specifies the environmental stratification. That is, when there is 
nonadditivity of genotype and environment, the effect of a genotype is defined as a 
function of both its contribution to the average phenotype over all environments and its 
differential response as it interacts with specific subsets of environments. In addition, it 
must be emphasized that such an interpretation holds only when there is no correlation 
between genotype and environmental values. 
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Fig. 6. Variances of In cholesterol in 5-yr age cohorts for males and females, ignoring markers. 
Figure 6 shows the variances for each 5-yr age cohort by sex, ignoring marker pheno- 
type. In the Tecumseh population we have found statistically significant heterogeneity of 
variance among age classes (ignoring marker phenotypes) in both sexes. Heterogeneity of 
variance of cholesterol among age classes, while rarely discussed, has been widely 
reported [29-321. However, comparing the patterns of variance over age from the above 
studies to those we observed is inappropriate since the cholesterol data from the other 
studies were not In-transformed. In these other data sets the variance of cholesterol 
values is highly correlated with the mean, a fact we reported earlier for the Tecumseh 
data [lS]. One noteworthy observation from the aforementioned studies is that in 3 of 
the 4 [30-321 there is an increase in variance of cholesterol which is disproportionately 
large compared to the increase in mean cholesterol for females around age 20. This is 
consistent with the finding in our study that the variance of In cholesterol for females is 
high in the age cohort 20-24. Heterogeneity of variance among age classes might be 
attributable to unmeasured genes whose effects are expressed only at certain develop- 
mental stages in life or environmental conditions which are experienced only by individ- 
uals in certain age cohorts. 
Up to age 45, the variance for males exceeded that for females, except in the age class 
30-34. (In two of the age cohorts, 10-14 and 25-29, the differences were statistically 
significant.) After age 45, there was no pattern of relationship between the variances in 
the two sexes, although in the age class 70-74, females had significantly greater variance 
than males. Similar results have been observed in a population of working Canadians 
[31], in a combination of 10 populations from the LRC studies [29], and in families from 
Muscatine, Iowa [32]. In these studies, however, the variance for females exceeded that 
for males in the age class 20-24, rather than age 3G34, as we observed in Tecumseh. 
When we examined the variances over age within marker phenotypes, we found ad- 
ditional differences between the sexes. The pattern of change in variance over age differed 
significantly among phenotypes in only one of the 12 independent marker systems we 
considered for males; for females 8 of the 12 systems showed evidence of MP x A 
interaction. What environments varying with age might be interacting with genotype to 
affect the stability of serum cholesterol? Since the significant MP x A interaction effects 
we observed were found only in females, the environments which are combining with 
different genotypes to cause heterogeneous variation are likely to be unique to females. 
One such environmental factor may well be sex hormones. Many investigators have 
found significant associations between mean cholesterol levels and hormone usage, 
although the results have not been consistent and most studies have been based on small 
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samples. Furman [33] and Bierman [34] review the work in this area. In the LRC 
studies of 10 diverse North American populations, women up to age 49 using oral 
contraceptives and estrogen preparations had greater plasma cholesterol levels than 
those not taking sex hormones [29] and the increase in cholesterol level associated with 
hormone usage was consistent over the 10 populations [35]. While we are aware of no 
studies which examine the variance of hormone levels over age or cholesterol variance at 
different levels of exogenous hormones and while we have no information on hormone 
levels in Tecumseh, it seems reasonable to hypothesize that individual variability of sex 
hormone levels might be involved in altering the stability of cholesterol levels in specific 
genotype-age classes. At the very least, such a hypothesis merits further investigation 
when the appropriate data are available. 
The results obtained from our study of means show that there are significant effects on 
mean serum cholesterol which are associated with marker phenotypes and that they are 
independent of macroenvironments which vary with age, i.e. the differences in cholesterol 
levels among marker phenotypes remain constant throughout the age range 492. The 
marker phenotype effects we observed are consistent with those effects seen in our earlier 
study [14] and other studies where the effects were not examined over age. Many studies 
have found the A-carrying phenotypes of the ABO system to be associated with higher 
levels of cholesterol than non-A phenotypes, while a number of reports indicate that 
nonsecretors have greater cholesterol levels on average than secretors. Mayo et al. [36] 
suggest that the association between ABO phenotypes and serum cholesterol ‘is possibly 
related to the role of cholesterol in the erythrocyte membrane, of which the ABO anti- 
gens form a part’. 
Upon examination of the multilocus phenotypes defined above, we found that mean 
cholesterol increased with the number of positive marker effects. In addition, we found 
that, as in the single-locus markers, there was no significant multilocus phenotype by age 
interaction of means. Although the single-locus marker phenotype differences that we 
have identified were small, the fact that these differences were consistent over age, the fact 
that they were consistent with differences observed in other populations, and the fact that 
together they additively predicted larger differences combine to provide strong evidence 
that genetic variation is indeed responsible for at least a fraction of the normal choles- 
terol variability in human populations. 
In addition to genes with small effects, such as those we examined above, major genes. 
such as the gene governing familial hypercholesterolemia (FH), may contribute to choles- 
terol variability. Figure 7 presents the predicted regressions of In cholesterol on age for 
hypercholesterolemic and normal males and females who are members of a 195member 
kindred described by Elston and his colleagues [37]. Figure 7 shows that the mean 
cholesterol of males with the hypothesized FH gene was much greater than that of 
normal males, but the changes with age in the two groups did not differ greatly. Females 
with the hypothesized FH gene had mean cholesterol which was much higher than that 
of normal females at very young ages, and their mean cholesterol increased significantly 
more rapidly with age than normal females. 
Figures 5 and 7 provide a comparison of two types of genetic effect which are import- 
ant in determining cholesterol variability. The rare FH gene causes serum cholesterol to 
reach extremely high levels, and there is some preliminary indication (from the females) 
that a genotype by age interaction may be present. The genes identified by the unlinked 
polymorphic genetic markers we have studied are associated with small, significant differ- 
ences in cholesterol levels which are consistent over all ages and combine to define larger 
differences which are also consistent over all ages. We interpret this consistency over age 
to mean that any of the macroenvironments which are changing with age are not directly 
involved in modifying the differences in the small gene effects. 
It appears. from consideration of the complexity of the biochemistry of lipoprotein 
metabolism and the consistency of results from a number of genetic epidemiological 
studies [38], that we might expect a large number of genetic loci to be involved in 
modulating serum cholesterol levels among randomly chosen individuals in huma.n 
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Fig. 7. Third-order regressions of In cholesterol on age for individuals with familial hypercholes- 
terolemia (FH) and those who do not have FH from the 19%member kindred described by Elston 
el al. [37]. 
populations. Of the 12 polymorphic genetic markers we studied, that as many as 6 
predicted small differences in serum cholesterol levels (while we know of only a few loci 
with major effects on cholesterol levels [39]) strongly suggests that a large fraction of the 
loci involved in determining serum cholesterol levels determine small effects. It seems 
likely, to us as well as to Edwards [40], that there is a distribution of the size of gene 
effects, wherein the loci with large effects (the major genes) are few in number, with alleles 
rare in frequency, and loci with small and additive effects (the polygenes) are the most 
common, and polymorphic. 
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